子分类：
| 序号 | 专利名 | 申请号 | 申请日 | 公开（公告）号 | 公开（公告）日 | 发明人 |
|---|---|---|---|---|---|---|
| 121 | Pharmaceutical composition for inhibiting viruses and increasing immune function (PII) | US396333 | 1989-08-21 | US4985247A | 1991-01-15 | Yaguang Liu |
| A safe pharmaceutical composition for treatment and prevention of infections caused by viruses and increasing immune function. The pharmaceutical composition is composed of four active ingredients: Polysaccharides of Wang Qi, Banlankensu, Yejuhua-flavonoid and Guanzhongsu and method of making the same. | ||||||
| 122 | Method for the recovery of steviosides from plant raw material | US221811 | 1988-07-20 | US4892938A | 1990-01-09 | Roger H. Giovanetto |
| The invention relates to a method for recovering steviosides from dried plant material of Stevia rebaudiana Bertoni by extraction and purification. An extract is obtained through treatment in water at a temperature from room temperature to about 65.degree. C. with stirring and subsequent filtration and centrifugation. This extract is treated with calcium hydroxide, whereupon a precipitate is obtained by means of filtration or centrifugation. This precipitate is treated with a strongly acidic ion exchange resin and subsequently with a weakly basic ion exchange resin, filtered and dried. | ||||||
| 123 | Pharmaceutical composition for inhibiting viruses and increasing immune function (PII) | US6736 | 1987-01-27 | US4886666A | 1989-12-12 | Yaguang Liu |
| A safe pharmaceutical composition for treatment and prevention of infections caused by viruses and increasing immune function. The pharmaceutical composition is composed of four active ingredients: Polysaccharides of Wang Qi, Banlankensu, Yejuhua-flavonoid and Guanzhongsu and method of making the same. | ||||||
| 124 | Skin therapeutic mixture containing eupatorium extract and formulations | US877132 | 1986-06-23 | US4880627A | 1989-11-14 | Theodore Trenzeluk |
| According to the present invention, a skin therapeutic mixture is useful for the alleviation of certain skin disorders such as acne, psoriasis, burns, pimples, blackheads, and open sores, and such mixture comprises: the therapeutic agent being the extract from the dried leaves of the Eupatorium plant; a preservative chosen from the group consisting of a sulfa-derivative such as sulfathiazole and an alcohol amine; a skin softener such as an oil; and an oil soluble base. An inert pigment such as zinc oxide and a fragrance such as a perfume may be added. According to a specific illustrative embodiment of the present invention, the skin therapeutic mixture comprises about 7.4% by weight of the extract from the dried leaves of the Eupatorium plant as the therapeutic agent; about 3.7% by weight of sulfathiazole as the preservative; about 14.2% by weight of zinc oxide as the inert white pigment; and about 74.7% by weight of petrolatum. | ||||||
| 125 | Pharmaceutical compositions for reducing hyperlipidemia and platelet-aggregation | US905554 | 1986-09-08 | US4842859A | 1989-06-27 | Yaguang Liu |
| The new pharmaceutical compositions and processes are provided for reducing both hyperlipidemia and platelet-aggregation (PHP).The fine-PHP is composed of following ingredients: Scoparone or Aurapten, Curcumin, Ferulic Acid, Yejuhua-flavonoid and additive ingredient--fish oil. The compositions are nontoxic. | ||||||
| 126 | Skin therapeutic mixture containing eupatorium extract | US795882 | 1985-11-07 | US4713242A | 1987-12-15 | Theodore Trenzeluk |
| According to the present invention, a skin therapeutic mixture is useful for the alleviation of certain skin disorders such as acne, psoriasis, burns, pimples, blackheads, open sores, and other conditions and such mixture comprises: the therapeutic agent being the extract from the dried leaves of the Eupatorium plant; a preservative chosen from the group consisting of a sulfa-derivative such as sulfathiazole and an alcohol amine; a skin softener such as an oil; and an oil soluble base. An inert pigment such as zinc oxide and a fragrance such as a perfume may be added. According to a specific illustrative embodiment of the present invention, the skin therapeutic mixture comprises about 7.4% by weight of the extract from the dried leaves of the Eupatorium plant as the therapeutic agent; 3.7% by weight of sulfathiazole as the preservative; about 14.2% by weight of zinc oxide as the inert white pigment; and about 74% by weight of petrolatum. | ||||||
| 127 | Nutritive compositions containing fatty substances and a process for the preparation thereof | US542149 | 1983-10-14 | US4703060A | 1987-10-27 | Helmut Traitler; Heike Winter |
| The oil of pips of fruits of the Ribes genus is an abundant, cheap source of .gamma.-linolenic acid.It is extracted using solvents from dried and ground residues from the production of juices, preserves and jellies or brandies, liqueurs and schnapps of fruits, such as blackcurrant, redcurrant or gooseberry. According to a preferred embodiment, the residues are treated with ethanol before being extracted with hexane in order to free the oil from most of the free fatty acids, waxes, colorings and odorous compounds.The refined oil is a valuable ingredient in cosmetic, dermatological, dietetic and pharmaceutical compositions. | ||||||
| 128 | Preparation for reducing cancer symptoms without treating cancer | US701458 | 1985-02-14 | US4618495A | 1986-10-21 | Hiromichi Okuda; Hiroshi Masuno; Masaki Aburada; Shigefumi Takeda; Eiko Itoh; Moe Matsushita; Eikichi Hosoya |
| A composition for reducing cancer symptoms by improving lipid metabolism and eliminating or reducing anorexia in tumor-bearing patients through inhibition of the lipid degradation-promoting action of toxohormone L which comprises an aqueous or aqueous organic solvent extract of one or more crude preparations selected from the group consisting of Astragali radix, Cinnamomi cortex, Rehmanniae radix, Paeoniae radix, Cnidii rhizoma, Atractylodis lanceae rhizoma, Angelicae radix, Ginseng radix, Hoelen and Glycyrrhizae radix, a method for preparing such a composition, and a method for reducing cancer symptoms using the composition. | ||||||
| 129 | Compositions for the post-treatment of seborrheal, acneiform processes and a process for the preparation thereof | US651608 | 1984-09-17 | US4614652A | 1986-09-30 | Gabriella Valyi; Eva Kutassy |
| The invention relates to a cosmetic composition for the post-treatment of seborrheal, acneiform processes, characterized by containing(i) an extract of dried chamomile (Matricaria chamomilla) and dried St. John's wort (Hypericum perforatum) in apple brandy and/or gooseberry brandy,(ii) an extract of propolis in apple brandy and/or gooseberry brandy, and(iii) a known ceratoplastic agent. | ||||||
| 130 | Extraction of camomile with liquid carbon dioxide | US618765 | 1984-06-11 | US4592911A | 1986-06-03 | Norbert Behr; Othmar von Ettingshausen; Reinhold Wust; Henk van der Mei, deceased |
| Extraction of commercially useful aromatic substances, fragrances and medicinal products from camomile is accomplished using liquid carbon dioxide. Good yields of heat labile components are obtained by this process. | ||||||
| 131 | Therapeutic compositions having antibacteric activity comprising a fraction extracted from camomile flowers and process for the preparation of said fraction | US499894 | 1983-06-01 | US4584198A | 1986-04-22 | Aurelia Tubaro; Roberto Della Loggia; Elena Banfi; Marina Cinco; Claudio Redaelli |
| A new lipophobic fraction has been prepared by the extraction of camomile flowers with boiling ethyl or methyl alcohol, which can contain up to 30% water, letting the alcoholic solution evaporate to obtain a residue and washing the obtained residue with the appropriate organic solvents.This fraction is particularly free of any of the camomile extract components that are volatile in steam current and the fraction has a strong bacteriostatic and bactericidal action.Therapeutic compositions having antibacterial action were prepared, using the lipophobic fraction of the camomile extract prepared as described above. | ||||||
| 132 | Extraction, separation and recovery of diterpene glycosides from Stevia rebaudiana plants | US265905 | 1981-05-21 | US4361697A | 1982-11-30 | Robert H. Dobberstein; Mohamed S. Ahmed |
| A process for recovering diterpene glycosides from the Stevia rebaudiana plant includes the steps of sequentially extracting plant material with a first solvent of intermediate polarity to extract plant substances which tend to interfere with a liquid chromatographic separation of the glycosides, and then with a second solvent of high polarity to extract glycosides, and chromatographically separating the extracted glycosides by introducing them onto a liquid chromatography column having a packing of an oxygen-containing organic stationary phase covalently bonded through a silicon atom to an inorganic support, eluting them with a solvent of polarity higher than that of the first solvent but lower than that of the second solvent, and collecting individually eluate fractions rich in respective glycosides. | ||||||
| 133 | Medicinal composition for external use for treating wounds | US162313 | 1980-06-23 | US4318906A | 1982-03-09 | Jean-Paul Llopart |
| A liquid medicinal composition for external use for treating wounds comprises from 450 to 1,000 ml of base tincture of Centella asiatica, from 11 to 65 ml of natural essential oil of Lavandula officinalis, from 5 to 10 ml of natural essential oil of Thymus officinalis, from 5 to 20 ml of natural essential oil of Rosmarinus officinalis and from 4 to 14 ml of base tincture of Aesculus hippocastunum and preferably also from 0.1 to 6 ml of base tincture of Medicago sativa, from 0.1 to 6 ml of base tincture of Carlina acaulis, and from 2 to 15 ml of natural essential oil of Cupressus officinalis. This composition speeds healing of wounds to a surprising degree. | ||||||
| 134 | Method and compound for treatment of arthritic conditions in dogs | US964332 | 1978-11-27 | US4258035A | 1981-03-24 | Janice A. Spies |
| The invention is:A composition composed of Comfrey, Mullein, Fenugreek, Nettle, Broom Tops, Boneset, herbal plants occurring in nature which may be cultivated. This composition when added to the regular food of dogs, has alleviated symptoms of arthritic spinal conditions in dogs. | ||||||
| 135 | Pain relief composition and method of preparing same | US167 | 1979-01-02 | US4177266A | 1979-12-04 | Mary A. Moore |
| A pain relief composition and method of preparing such for producing a therapeutic composition for topical application to the skin to provide symptomatic pain relief from a number of conditions such as arthritis. The pain relief composition is prepared from roots of the family of Burdock plants and in particular from at least one of the species Arctium lappa as Arctium minus in combination with roots of the Phytolacca family and in particular the species Phytolacca americana. The combination of roots are inserted into a receptacle containing water. The initial mixture is heated until boiling occurs and the mixture is continually boiled for a predetermined time interval until a coloration change of the substantially transparent water is seen to occur. There is formed a substantially darkened gray colored suspension which has found to include an extract of the combination of the Phytolacca and Burdock roots with some remaining extraneous bulk material. The suspension is cooled by exposing it to the atmosphere until room temperature is achieved. A predetermined quantity of isopropyl alcohol is stirred or otherwise mixed into the aqueous suspension subsequent to the bulk material being removed therefrom. The resulting pain relief composition is then available for external application to the skin of a user. | ||||||
| 136 | Utero-evacuants | US903456 | 1978-05-08 | US4176188A | 1979-11-27 | Ramesh M. Kanojia; Michael P. Wachter; Robert H. K. Chen |
| Chemical compounds having a substituted oxepane ring and methods of preparing such compounds are described. The compounds are active as utero-evacuant agents. | ||||||
| 137 | Chrysanthellum plant extract | US870649 | 1978-01-19 | US4146615A | 1979-03-27 | Francois Fauran; Gisele Prat; Annie Thibault; Claude Andre-Mouries; Henri Combier |
| A plant extract rich in triterpenic constituents obtained from chrysanthellum and containing as principle component a triterpenic saponin derivative of echinocystic acid whose glycoside contains rhamnose, glucose and xylose may be prepared by extraction of chrysanthellum plants. The extract has been shown to have pharmacological activity, especially analgesic, anti-inflammatory, capillaroprotective and anti-ulcer activity. | ||||||
| 138 | Chemical products and methods | US838527 | 1977-10-03 | US4130556A | 1978-12-19 | Michael P. Wachter; Ramesh M. Kanojia |
| Novel compounds obtained from the zoapatle plant and methods of obtaining these compounds from the plant material are described. The novel compounds possess useful activity as central nervous system depressants as well as utero-evacuants. | ||||||
| 139 | Isolation of uteroevacuant substances from plant extracts | US822478 | 1977-08-08 | US4112078A | 1978-09-05 | Robert H. K. Chen |
| A method of obtaining uteroevacuant substances from the zoapatle plant is described. The isolation and purification of biologically-active compounds from the zoapatle plant is accomplished by chemical means. | ||||||
| 140 | Purification of utero-evacuant extracts from plant substances | US672918 | 1976-04-02 | US4086358A | 1978-04-25 | Michael P. Wachter; Ramesh Maganlal Kanojia |
| Novel compounds obtained from the zoapatle plant and methods of obtaining these compounds from the plant material are described. The novel compounds possess useful activity as central nervous system depressants as well as utero-evacuants. | ||||||
QQ群二维码
意见反馈
意见反馈